Consun Pharmaceutical Group (HKSE:01681) Net Margin % : 31.51% (As of Jun. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Consun Pharmaceutical Group Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Consun Pharmaceutical Group's Net Income for the six months ended in Jun. 2024 was HK$430 Mil. Consun Pharmaceutical Group's Revenue for the six months ended in Jun. 2024 was HK$1,366 Mil. Therefore, Consun Pharmaceutical Group's net margin for the quarter that ended in Jun. 2024 was 31.51%.

The historical rank and industry rank for Consun Pharmaceutical Group's Net Margin % or its related term are showing as below:

HKSE:01681' s Net Margin % Range Over the Past 10 Years
Min: 4.62 Med: 28.66 Max: 30.53
Current: 30.53

HKSE:01681's Net Margin % is ranked better than
95.38% of 995 companies
in the Drug Manufacturers industry
Industry Median: 3.96 vs HKSE:01681: 30.53

Consun Pharmaceutical Group Net Margin % Historical Data

The historical data trend for Consun Pharmaceutical Group's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Consun Pharmaceutical Group Net Margin % Chart

Consun Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

Get a 7-Day Free Trial

4.62

28.46

28.86

29.19

30.29

Consun Pharmaceutical Group Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Net Margin %	Get a 7-Day Free Trial															29.87	28.69	31.07	29.69	31.51

Competitive Comparison of Consun Pharmaceutical Group's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Consun Pharmaceutical Group's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Consun Pharmaceutical Group's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Consun Pharmaceutical Group's Net Margin % distribution charts can be found below:

* The bar in red indicates where Consun Pharmaceutical Group's Net Margin % falls into.

Consun Pharmaceutical Group Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Consun Pharmaceutical Group's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	858.107	/	2833.013
	=	30.29 %

Consun Pharmaceutical Group's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin	=	Net Income (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	430.364	/	1365.648
	=	31.51 %

Consun Pharmaceutical Group (HKSE:01681) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Consun Pharmaceutical Group Net Margin % Related Terms

Thank you for viewing the detailed overview of Consun Pharmaceutical Group's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Consun Pharmaceutical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Consun Pharmaceutical Group Ltd (HKSE:01681) » Definitions » Net Margin %

Traded in Other Exchanges

C1P:Germany

Address

71, Dongpeng Avenue, Eastern section, Guangzhou Economic and Technological Development, Guangzhou, CHN

Website

https://www.chinaconsun.com

Consun Pharmaceutical Group Ltd is a biotechnology company with a modern pharmaceutical enterprise that integrates R&D, production, and marketing. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.

Executives

Double Grace International Limited	2101 Beneficial owner
Li Qian	2101 Beneficial owner
An Yubao	2101 Beneficial owner
Central Success Developments Limited	2101 Beneficial owner
Aali Resources Limited	2201 Interest of corporation controlled by you
Bos Trustee Limited	2301 Trustee
Zhang Lihua	2202 Interest of your spouse
An Meng	2101 Beneficial owner
Bos Trustee Limited As Trustee	2201 Interest of corporation controlled by you

Consun Pharmaceutical Group Headlines

No Headlines